June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Vitamin A aldehyde-taurine adduct and the visual cycle
Author Affiliations & Notes
  • Hye Jin Kim
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jin Zhao
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Janet R. Sparrow
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
    Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   Hye Jin Kim, None; Jin Zhao, None; Janet Sparrow, None
  • Footnotes
    Support  NH Grant EY028131 and P30EY019007
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3010. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hye Jin Kim, Jin Zhao, Janet R. Sparrow; Vitamin A aldehyde-taurine adduct and the visual cycle. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3010.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Continued light sensitivity necessitates the regeneration of 11-cis-retinal via a series of enzyme-catalyzed steps within the visual cycle. During this process vitamin A aldehyde is shepherded within photoreceptors and retinal pigment epithelial cells by retinoid-binding proteins and NRPE to facilitate retinoid trafficking, to prevent non-specific aldehyde reactivity and to conserve the 11-cis configuration. Least understood is a Schiff base adduct (A1T) that forms non-enzymatically and reversibly from reactions between taurine and vitamin A-aldehyde and is abundant in neural retina of humans and mice.

Methods : Retinoids (derivatized with O-ethylhydroxylamine (100 mM) in DPBS) and bisretinoids, taurine and β-alanine (derivatived with NBD-F) were quantified by HPLC and UPLC with reference to authentic standards. A1T was synthesized by reacting retinaldehyde with taurine (1:1 molar ratio of retinal isomers and taurine) in dehydrated methanol containing sodium methoxide. ONL area was calculated as the sum of the ONL thicknesses in superior and inferior retina (0.2–2.0 mm) multiplied by the measurement interval of 200 microns.

Results : Reduction in cellular taurine by treatment with the taurine transport inhibitor β-alanine (in drinking water, 2%; 2 months) accentuated the thinning of outer nuclear layer (ONL) expected in albino Abca4-/- mice. β-alanine-treatment reduced bisretinoid levels. When mice were treated with taurine (2.5% in drinking water for 2, 4 and 6 months) ONL thinning in albino Abca4-/- mice was reduced.

Conclusions : We previously observed that A1T is more abundant under conditions in which 11-cis-retinaldehyde is present at higher levels, including black versus albino mice, dark-adapted versus light-adapted mice and mice carrying the Rpe65-Leu450 versus Rpe65-450Met variant. The accentuated ONL thinning indicative of photoreceptor cell loss, is consistent with previous reports of photoreceptor cell death in the presence of taurine deficiency; perhaps the worsening of ONL thinning occurs due to inadequate 11-cis-retinal handling. The reduction in bisretinoid levels with b-alanine treatment suggests that the intent of A1T formation is not to protect against unwanted bisretinoid formation as might be supposed. Rather A1T may serve to preserve retinaldehyde.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×